Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Vibrating pads might keep muscles strong while You're laid up

NCT ID NCT07021079

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a small vibrating device placed on the thigh can prevent muscle loss when a leg is immobilized. Forty-two healthy adults will have one leg in a cast for several days. Half will receive daily vibration sessions; the other half will not. Researchers will measure changes in muscle strength and jump performance to see if the vibration helps maintain muscle function.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
focal muscle vibration (device)
What this could lead to
If it works, this could point toward a simple, non-invasive way to prevent muscle loss during bed rest or cast immobilization.
What could go wrong
This is a small, early-stage study in healthy volunteers, not patients. The results may not apply to real-world medical conditions, and the vibration may not prevent muscle loss.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 42 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 45 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men and women. * Aged 18 to 45 years. * Body Mass Index (BMI) between 18,5 and 24,9 kg/m². * Engaging in at least 1.5 hours per week of physical activity (e.g., brisk walking, running, swimming, cycling). * Provided informed consent after receiving detailed information about the study. * Affiliated with or beneficiaries of a social security system Exclusion Criteria: * Chronic cardiovascular, neuromuscular, bone, metabolic, and/or inflammatory disorders. * Personal history and/or risk factors for thrombosis. * Use of antidepressant medications. * Use of neuroactive substances likely to alter corticospinal excitability (e.g., hypnotics, antiepileptics, psychotropics, muscle relaxants) during the study. * Recent bone or ligament trauma within the past 12 months. * Inability to perform the physical efforts required for the study. * Recent participation in a sporting competition or intense, unusual physical activity within the past month. * Corticosteroid treatment within the past 3 months. * Any skin lesions at the planned vibrator application site. * Simultaneous participation in another interventional medical study. * Pregnant or breastfeeding women. * Individuals unable to understand the purpose and conditions of the study or unable to provide informed consent. * Individuals deprived of liberty or under guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy volunteer study are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Sedentary Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre Hospitalier Universitaire

    RECRUITING

    Saint-Etienne, 42055, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.